ImmunotherapyImmunotherapy, AdoptiveImmunotherapy, ActiveDesensitization, ImmunologicTreatment OutcomeCancer VaccinesAdministration, SublingualAntigens, NeoplasmSublingual ImmunotherapyNeoplasmsAntibodies, MonoclonalRhinitis, Allergic, SeasonalDouble-Blind MethodClinical Trials as TopicT-Lymphocytes, CytotoxicAllergensMelanomaDendritic CellsT-LymphocytesAntineoplastic AgentsDrug Therapy, CombinationInterleukin-2Cell Line, TumorDrug Administration ScheduleCD8-Positive T-LymphocytesAdministration, OralDose-Response Relationship, DrugRhinitis, Allergic, PerennialMice, Inbred C57BLCombined Modality TherapyTime FactorsLymphocytes, Tumor-InfiltratingMice, Inbred BALB CPollenMelanoma, ExperimentalLymphocyte ActivationImmunization, PassiveImmunoglobulin ECytotoxicity, ImmunologicDisease Models, AnimalInjections, SubcutaneousAdjuvants, ImmunologicHLA-A2 AntigenBee VenomsRandomized Controlled Trials as TopicInterferon-gammaImmunologic FactorsTumor EscapeBCG VaccineDrug CombinationsSneezingFlow CytometryCD4-Positive T-LymphocytesProspective StudiesCytokinesAntigens, PlantParietariaFollow-Up StudiesAlzheimer VaccinesCytokine-Induced Killer CellsHypersensitivityAnti-Bacterial AgentsInsect Bites and StingsEpitopes, T-LymphocyteAntibodies, NeoplasmRecombinant ProteinsAntibodies, Monoclonal, HumanizedKidney NeoplasmsHLA-A24 AntigenTumor Cells, CulturedGenetic TherapyNeoplasms, ExperimentalImmunoglobulin GCarcinoma, Renal CellAdministration, TopicalMice, TransgenicHLA-A AntigensGenetic VectorsNeoplasm TransplantationMelanoma-Specific AntigensAntigens, CD20Antineoplastic Combined Chemotherapy ProtocolsLung NeoplasmsPilot ProjectsRecurrenceVaccinationgp100 Melanoma AntigenKiller Cells, NaturalAntibodies, Monoclonal, Murine-DerivedNeoplasm MetastasisT-Lymphocytes, RegulatoryPicibanilSafetySkin NeoplasmsDrug SynergismAntigen PresentationSurvival AnalysisImmune ToleranceWasp VenomsEnzyme-Linked Immunosorbent Assay